24 January 2013
Louise Beange has written an interesting post on our sister blog In Competition about an ‘amicus brief’ issued by the US Federal Trade Commission (FTC) indicating that an incident of ‘product switching’ in the pharmaceutical industry by Warner Chilcott may be a breach of anti-trust laws. Read more about it here.
We’ve previously posted about similar issues on IP Whiteboard here and here.
